Delivery Order SPE2DB20D7061-SPE2DB23FSNH4

Award Date 4/1/23
Potential Completion Date 4/3/23
Potential Value $3.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.43 firm fixed-price delivery order contract covers NYSTATIN-TRIAMCINOLONE CREAM 15GM, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,717.90, is a Firm Fixed Price Delivery Order for the supply of Nystatin 100,000 Unit/mL Suspension in 473 mL bottles. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order worth $1,010.46 for the supply of NYSTATIN-TRIAMCINOLONE CREAM 60GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on November 9, 2023, with a completion date of November 13, 2023. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of Nystatin 100,000 Unit/mL Suspension in a 473 mL bottle, procured by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $2,365.92 and is a Firm Fixed Price Delivery Order with a completion date of September 16, 2024. This award is not associated with a set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,755.66 firm fixed-price contract is for the supply of 4,567,341,454 units of Nystatin 100,000 unit/mL suspension in 60 mL bottles. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This contract award is associated with...
This federal contract award, valued at $1,274.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the procurement of 4562669454 ! SF 5000 PLUS CREAM 51GM. The contract has a firm fixed price and an ultimate completion date of November 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $4,273.51, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naftifine HCL 2% Cream, a topical antifungal medication, with a period of performance through December 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for the pharmaceutical product NORITATE 1% CREAM 60GM valued at $19,730.86. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $5,727.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Opzelura 1.5% cream, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026, which covers a comprehensive...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB23FSNH4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.57, is for the delivery of Nystatin 100,000 unit/gm cream 30gm.

The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/9/25, 10:10 AM